on March 27, 2006
Published online before print March 27, 2006, doi: 10.1161/01.HYP.0000215363.69793.bb
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 21, 2005
From the Clinica Medica (G.M., R.F., M.B., G.G., R.S.), Università Milano-Bicocca, Ospedale San Gerardo; Centro Interuniversitario di Fisiologia Clinica e Ipertensione (G.M., R.F., M.B., G.G., R.S.), and Centro Auxologico Italiano (G.M., G.G.), Milan, Italy. * To whom correspondence should be addressed. E-mail: giuseppe.mancia{at}.
Abstract--In the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study, office, home, and ambulatory blood pressure (BP) values were measured contemporaneously between 1990 and 1993 in a large population sample (n=2051). Cardiovascular (CV) and non-CV death certificates were collected over the next 148 months, which allowed us to assess the prognostic value of selective and combined elevation in these 3 BPs over a long follow-up. There were 69 CV and 233 all-cause deaths. Compared with subjects with normal office and 24-hour BP, the hazard ratio for CV death showed a progressive increase in those with a selective office BP elevation (white-coat hypertension), a selective 24-hour BP elevation (masked hypertension), and elevation in both office and 24-hour BP. This was the case also when the above conditions were identified by office versus home BP values. Selective elevation in home versus ambulatory BP or vice versa also carried an increased risk. There was indeed a progressive increase in both CV and all-cause mortality risk from subjects in whom office, home, and ambulatory BP were all normal to those in whom 1, 2, or all 3 BPs were elevated, regardless of which BP was considered. The trends remained significant after adjustment for age and gender, as well as, in most instances, after further adjustment for other cardiovascular risk factors. Thus, white-coat hypertension and masked hypertension, both when identified by office and ambulatory or by office and home BPs, are not prognostically innocent. Indeed, each BP elevation (office, home, or ambulatory) carries an increase in risk mortality that adds to that of the other BP elevations.
Revised on December 21, 2005
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
Giuseppe Mancia*;
Key words: blood pressure monitoring, ambulatory • hypertension, white-coat • cardiovascular diseases
Related Article:
Hypertension 2006 47: 820-821.
This article has been cited by other articles:
 |
|
 |
|
  G. Mancia and G. Corrao Targeting blood pressure in the management of total cardiovascular risk Eur. Heart J. Suppl., December 1, 2009; 11(suppl_F): F27 - F32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mancia, R. Sega, M. Bombelli, F. Quarti-Trevano, R. Facchetti, and G. Grassi Should White-Coat Hypertension in Diabetes Be Treated? Pro Diabetes Care, November 1, 2009; 32(suppl_2): S305 - S309. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, F. Quarti-Trevano, H. P. Friz, G. Grassi, and R. Sega Response to Long-Term Risk in Subjects With White-Coat Hypertension Hypertension, November 1, 2009; 54(5): e134 - e134. [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, F. Quarti-Trevano, H. P. Friz, G. Grassi, and R. Sega Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension Hypertension, August 1, 2009; 54(2): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Parati, S. Omboni, and G. Bilo Why Is Out-of-Office Blood Pressure Measurement Needed?: Home Blood Pressure Measurements Will Increasingly Replace Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension Hypertension, August 1, 2009; 54(2): 181 - 187. [Full Text] [PDF]
|
|
|
|
|
|
P. Verdecchia, F. Angeli, G. Mazzotta, G. Gentile, and G. Reboldi Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring Hypertension, August 1, 2009; 54(2): 188 - 195. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kjeldsen, T. A. Aksnes, R. H. Fagard, and G. Mancia CHAPTER 13 Hypertension ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J McManus, P. Glasziou, A. Hayen, J. Mant, P. Padfield, J. Potter, E. P Bray, and D. Mant Blood pressure self monitoring: questions and answers from a national conference BMJ, December 22, 2008; 337(dec22_1): a2732 - a2732. [Full Text]
|
|
|
|
 |
|
 B. M. Egan, S. D. Nesbitt, and S. Julius Review: Prehypertension: should we be treating with pharmacologic therapy? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 305 - 314. [Abstract] [PDF]
|
|
|
|
|
|
T. G. Pickering, N. H. Miller, G. Ogedegbe, L. R. Krakoff, N. T. Artinian, and D. Goff Call to Action on Use and Reimbursement for Home Blood Pressure Monitoring: A Joint Scientific Statement From the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association Hypertension, July 1, 2008; 52(1): 10 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grassi, F. Quarti-Trevano, and G. Mancia Review: Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 66 - 74. [Abstract] [PDF]
|
|
|
|
|
|
E. O'Brien Ambulatory Blood Pressure Measurement: The Case for Implementation in Primary Care Hypertension, June 1, 2008; 51(6): 1435 - 1441. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Williams The Year in Hypertension J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142. [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia Neurogenic Abnormalities in Masked Hypertension Hypertension, September 1, 2007; 50(3): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Minutolo, S. Borrelli, R. Scigliano, V. Bellizzi, P. Chiodini, B. Cianciaruso, F. Nappi, P. Zamboli, G. Conte, and L. De Nicola Prevalence and clinical correlates of white coat hypertension in chronic kidney disease Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2217 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Schwartz, K. R. Bailey, T. Mosley, D. S. Knopman, C. R. Jack Jr, V. J. Canzanello, and S. T. Turner Association of Ambulatory Blood Pressure With Ischemic Brain Injury Hypertension, June 1, 2007; 49(6): 1228 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mehta, J. E. Rame, A. Khera, S. A. Murphy, R. M. Canham, R. M. Peshock, J. A. de Lemos, and M. H. Drazner Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation Hypertension, June 1, 2007; 49(6): 1385 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Leitao, L. H. Canani, C. K. Kramer, J. C. Boza, A. F. Pinotti, and J. L. Gross Masked Hypertension, Urinary Albumin Excretion Rate, and Echocardiographic Parameters in Putatively Normotensive Type 2 Diabetic Patients Diabetes Care, May 1, 2007; 30(5): 1255 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Verdecchia, F. Angeli, and C. Cavallini Ambulatory Blood Pressure for Cardiovascular Risk Stratification Circulation, April 24, 2007; 115(16): 2091 - 2093. [Full Text] [PDF]
|
|
|
|
|
|
M. Kikuya, T. W. Hansen, L. Thijs, K. Bjorklund-Bodegard, T. Kuznetsova, T. Ohkubo, T. Richart, C. Torp-Pedersen, L. Lind, H. Ibsen, et al. Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk Circulation, April 24, 2007; 115(16): 2145 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia Effective Ambulatory Blood Pressure Control in Medical Practice: Good News To Be Taken With Caution Hypertension, January 1, 2007; 49(1): 17 - 18. [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia, R. Facchetti, M. Bombelli, G. Grassi, and R. Sega Response to White-Coat and Masked Hypertension: Selective Elevation of Blood Pressure or an Arbitrarily Partitioned Continuum? Hypertension, August 1, 2006; 48(2): e9 - e9. [Full Text] [PDF]
|
|
|
|
|
|
I. Z. Ben-Dov White-Coat and Masked Hypertension: Selective Elevation of Blood Pressure or an Arbitrarily Partitioned Continuum? Hypertension, August 1, 2006; 48(2): e8 - e8. [Full Text] [PDF]
|
|
|
|
|
|
P. Verdecchia, F. Angeli, and J. A. Staessen Compared With Whom?: Addressing the Prognostic Value of Ambulatory Blood Pressure Categories Hypertension, May 1, 2006; 47(5): 820 - 821. [Full Text] [PDF]
|
|